Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Helene Ruffieux
University of Cambridge - MRC Biostatistics Unit
Cambridge
United Kingdom
Contact
University of Cambridge - MRC Biostatistics Unit
Email
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
59
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Early Immune Pathology and Persistent Dysregulation Characterise Severe COVID-19
Number of pages: 105
Posted: 29 Dec 2020
Laura Bergamaschi
,
Federica Mescia
,
Lorinda Turner
,
Aimee Hanson
,
Prasanti Kotagiri
,
Benjamin J. Dunmore
, Helene Ruffieux,
Aloka de Sa
,
Oisin Huhn
,
Mark R. Wills
,
Stephen Baker
,
Rainer Doffinger
,
Gordon Dougan
,
Anne Elmer
,
Ian Goodfellow
,
Ravindra K. Gupta
,
Myra Hosmillo
,
Kelvin Hunter
,
Nathalie Kingston
,
Paul Lehner
,
Nicholas J. Matheson
,
Jeremy K. Nicholson
,
Anna M. Petrunkina
,
Sylvia Richardson
,
Caroline Saunders
,
James Thaventhiran
,
Erik J. M. Toonen
,
Michael P. Weekes
,
(CITIID-NIHR) COVID BioResource Collaboration Group
,
Mark Toshner
,
Christoph Hess
,
John R. Bradley
,
Paul A. Lyons
and
Kenneth G.C. Smith
University of Cambridge - Department of Medicine, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Department of Medicine, University of Cambridge - MRC Biostatistics Unit, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Department of Medicine, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Department of Medicine, NIHR Cambridge Clinical Research Facility, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, NIHR Cambridge Clinic Research Facility - Addenbrooke's Hospital, University of Cambridge - Division of Virology, Cambridge Institute of Therapeutic Immunology & Infectious Disease, Addenbrooke's Hospital - Division of Virology, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, NIHR Cambridge Biomedical Research Centre - NIHR BioResource, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, Murdoch University - The Centre for Computational and Systems Medicine, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - MRC Biostatistics Unit, NIHR Cambridge Clinic Research Facility - Addenbrooke's Hospital, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, Hycult Biotech - R&D Department, University of Cambridge - Cambridge Institute for Medical Research, Independent, Royal Papworth HospitalUniversity of Cambridge - Heart and Lung Research Institute, University Hospital Basel - Immunobiology Laboratory, University of Cambridge - Department of Medicine, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease and University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease
Downloads
59
(970,490)
View PDF
Download
Abstract:
Feedback